Jump to: Headline numbers | How retatrutide and Wegovy work | Why retatrutide produces more weight loss | Side effects compared | Cardiovascular and long-term safety | Muscle and lean mass | Drug interactions and contraception | Mental health | UK access today vs the realistic timeline | Switching considerations | Who should consider which | FAQs | Take home message | Second Natures Mounjaro programme | References In Phase 3 human trials, retatrutide leads to more average weight loss than Wegovy
FIGURE 3 Membrane Perturbing Effects of LCACs LCAC membrane incorporation has been modeled in purified phospholipid vesicles, with findings suggesting that LCACs alter the biophysical properties of cardiomyocyte membranes in a manner that could be linked to electrophysiological derangements (Requero et al., 1995a, b)
Patients with genetic predispositions toward heightened GI sensitivity may benefit from oral formulations, slower escalation protocols, or microdose approaches rather than standard injectable dosing, though provider assessment remains essential for individual medical decisions
In the chronic stress studies, caffeine was administered chronically but with variation in time of exposure in two [28], three [29], four [30], or six weeks [31]
An open question remains whether chronic use of GLP1RAs will result in tachyphylaxis of the gastric slowing effect, which will mitigate the risk of DDI [51,52,53]
